Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00609596 · ClinicalTrials.gov registry record · Phase 1
A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00609596 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 24 participants.
The verdict
NCT00609596, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
Dutasteride and tamsulosin are to treat benign prostatic hyperplasia. Studies show that when given together, there is more improvement in symptoms than either drug alone. In this study, we are looking to see if 2 different formulations of tamsulosin in our combination capsules are the same after 7 days of dosing as the US commercial tamsulosin and dutasteride.
Interventions
- DRUG GI198745
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-02-26 |
| Est. Completion | 2008-04-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00609596
The ClinicalTrials.gov registry entry for NCT00609596 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GI198745 is the first listed.
NCT00609596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00609596 about?
NCT00609596 is a clinical study titled "A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State.". Dutasteride and tamsulosin are to treat benign prostatic hyperplasia. Studies show that when given together, there is more improvement in symptoms than either drug alone. In this study, we are looking to see if 2 different formulations of tamsulosin in our combination capsules are the same after 7 d...
What is the current status of trial NCT00609596?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-02-26. Estimated completion is 2008-04-23.
What interventions are being tested in trial NCT00609596?
The interventions under investigation include: GI198745 (DRUG).
Who is sponsoring clinical trial NCT00609596?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.